Abstract

Background: Direct acting antivirals (DAAs) have simplified and expanded access to Hepatitis C virus (HCV) treatment. Only 17% of the 2.4 million Americans with HCV have linked to HCV care. We aimed to evaluate linkage to care (LTC) in a non-urban HCV referral clinic with a nurse navigator model and identify disparities in LTC.Methods: A single-center retrospective cohort analysis was performed among all patients referred to an infectious diseases HCV clinic between 2014 and 2018. The primary outcome was LTC, defined as attendance at a clinic appointment. A multivariable Poisson regression model estimated the association of variables with LTC.Results: Among 824 referred patients, 624 (76%) successfully linked to care and 369 (45%) successfully achieved sustained virologic response. Forty-six percent of those referred were uninsured. On multivariable analysis, LTC rates were higher among women (Incidence Rate Ratio [IRR] 1.11, 95% CI 1.03–1.20, p-value = 0.01) and people with cirrhosis (IRR 1.20, 95% CI 1.11–1.30, p-value < 0.001). Lower LTC rates were found for young people (<40 years; IRR 0.88, 95% CI 0.79–0.98, p-value = 0.02) and uninsured people (IRR 0.85, 95% CI 0.77–0.94, p-value = 0.002). Among those without LTC, 10% were incarcerated. Race, proximity to care, substance use, and HIV status were not associated with LTC.Conclusions: Using an embedded nurse navigator model, high LTC rates were achieved despite the prevalence of barriers, including a high uninsured rate. Disparities in LTC based on age, sex, and insurance status are present. Substance use was not associated with LTC. Future interventions to improve care should include expanded access to insurance and programs bridging care for incarcerated populations.

Highlights

  • The Centers for Disease Control and Prevention estimates that 2.4 million Americans are currently infected with hepatitis C virus (HCV) [1]

  • The HCV cascade of care defines the steps required to progress from diagnosis to cure and is generally structured around the steps of testing, linkage to care (LTC), and treatment, though the exact outcomes measured vary by study [5]

  • While guidelines recommend that all people with active HCV be linked to a clinician [6], LTC is frequently shown to be a point in the cascade where there is a large drop-off [5, 7,8,9,10]

Read more

Summary

Introduction

The Centers for Disease Control and Prevention estimates that 2.4 million Americans are currently infected with hepatitis C virus (HCV) [1]. The development of effective and well-tolerated direct acting antiviral (DAA) therapy has made the goal of HCV elimination possible [2, 3]. For those living with HCV, achieving cure is cost-effective and is associated with decreased complications of HCV and improvement in patient related outcomes [4]. The HCV cascade of care defines the steps required to progress from diagnosis to cure and is generally structured around the steps of testing, linkage to care (LTC), and treatment, though the exact outcomes measured vary by study [5]. Direct acting antivirals (DAAs) have simplified and expanded access to Hepatitis C virus (HCV) treatment. We aimed to evaluate linkage to care (LTC) in a non-urban HCV referral clinic with a nurse navigator model and identify disparities in LTC

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call